Yi Kuang

State Key Laboratory For Discovery And Utilization Of Functional Component In Traditional Chinese Medicine
Guiyang, 561113, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Yuxingcao formula suppresses acute erythroleukemia through inhibition of AKT1 and FLI1.

Yuxingcao formula suppresses acute erythroleukemia through inhibition of AKT1 and FLI1.

Journal: Fitoterapia
Published: September 01, 2025

L1, a 3,3'-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells.

L1, a 3,3'-diindolylmethane-derivative, induced ER stress-mediated apoptosis and suppressed growth through the FLI1/AKT pathway in erythroleukemia HEL cells.

Journal: Frontiers in pharmacology
Published: January 21, 2025

Vitamin D3 and its active form calcitriol suppress erythroleukemia through upregulation of CHAC1 and downregulation of NOTCH1.

Vitamin D3 and its active form calcitriol suppress erythroleukemia through upregulation of CHAC1 and downregulation of NOTCH1.

Journal: Medical oncology (Northwood, London, England)
Published: January 16, 2025

The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity.

The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity.

Journal: International journal of molecular sciences
Published: November 12, 2024

FLI1 Induces Plaque Psoriasis and Its Inhibition Attenuates Disease Progression.

FLI1 Induces Plaque Psoriasis and Its Inhibition Attenuates Disease Progression.

Journal: Journal of inflammation research
Published: October 22, 2024

UM171 suppresses breast cancer progression by inducing KLF2.

UM171 suppresses breast cancer progression by inducing KLF2.

Journal: Breast cancer research and treatment
Published: February 07, 2024

An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.

An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.

Journal: Molecular medicine reports
Published: December 08, 2023

FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.

FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression.

Journal: BMC cancer
Published: July 21, 2023

FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression.

FLI1 Regulates Histamine Decarboxylase Expression to Control Inflammation Signaling and Leukemia Progression.

Journal: Journal of inflammation research
Published: December 22, 2022

Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling.

Lovastatin inhibits erythroleukemia progression through KLF2-mediated suppression of MAPK/ERK signaling.

Journal: BMC cancer
Published: October 04, 2022

FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes.

FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes.

Journal: Medical oncology (Northwood, London, England)
Published: August 16, 2022
Showing 1-11 of 11

Last Updated: 09/26/2026